Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: INTRA-CELLULAR THERAPIES, INTRA-CELLULAR THERAPIES, INC., Intra-Cellular Therapies, Inc.
Client-Reported Lobbying Expenses
$605K
38 filings
Firm Income Reported for This Client
$550K
Not substituted for client expenses
Summary
INTRA-CELLULAR THERAPIES, INC. is an organization. Its political footprint includes $605K in client-reported lobbying expenses, $550K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations. Their largest government contract source is Department of Veterans Affairs at $0. Political activity spans from 2004 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↓ 62% YoY
2025: $80K (complete years)
Activity data: Senate LDA